ClinicalTrials.gg
Enrolling by invitationNCT07644676Updated Jun 12, 2026

The Impact of Adhesion Strategy on the Clinical Performance Of Indirect Dental Restorations

An interventional study of Resin cement and Glass-ionomer cement in Healthy Adult Participants and Tooth Fracture, sponsored by Malmö University. Enrolling by invitation at 2 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-12.

Sponsored by Malmö University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether different cement systems influence the clinical outcome of posterior tooth supported zirconia crowns in adult patients requiring single crown restorations. The main questions it aims to answer are:

  • Do glass ionomer cements provide clinical outcomes comparable to those of resin cements for posterior zirconia crowns?
  • Do marginal discoloration, marginal integrity, and biological complications differ between the cement systems?
  • Do patient reported and clinician reported outcomes differ between the cementation procedures?

Researchers will compare zirconia crowns cemented with either a glass ionomer cement or a resin cement to evaluate differences in clinical outcomes.

Participants will:

  • Receive posterior zirconia crowns fabricated according to standardized clinical procedures
  • Be randomized to cementation with either a glass ionomer cement or a resin cement
  • Undergo clinical examinations assessing crown survival, marginal adaptation, discoloration, caries, periodontal status, and wear
  • Complete questionnaires regarding patient comfort and treatment experience
  • Attend baseline and annual follow-up examinations for up to 10 years
Read the detailed description

Tooth damage has significant impact on a person's quality of life and damaged teeth should be treated to restore lost functions and prevent further damage. Loss of tooth substance can be restored by a direct (filling) or indirect restoration (artificial crown). These interventions differ in some operative aspects but share key challenges, particularly in achieving optimal adhesion to tooth substance to secure predictable retention and the integrity of the marginal seal.

Failure of the adhesive interface is a major determinant of restoration longevity and may manifest across patient-centered, biological, and technical outcomes.

Marginal degradation may result in discoloration, representing an early clinical indicator of interface breakdown that negatively affects patient satisfaction and may lead to a need for retreatment. Progressive marginal leakage facilitates bacterial access, increasing the risk of biological complications such as secondary caries and pulpal involvement.

Loss of retention represents a major technical complication, often requiring replacement of the restoration and contributing to cumulative loss of tooth structure over time.

Despite advances in restorative materials and adhesive systems, clinical outcomes remain variable, and the relative contribution of material properties, procedural complexity, and biological factors to long-term failure is not fully understood. In particular, the role of technique sensitivity and procedural complexity as independent determinants of restoration survival remains insufficiently characterized. Improved understanding of these interacting factors will enable more precise selection of restorative materials and cementation strategies.

This project will: (a) identify and quantify clinically relevant determinants of restoration failure, enabling improved prediction of restoration survival and patient satisfaction, (b) elucidate how interfacial degradation and technique sensitivity contribute to biological and technical complications, (c) aid clinical decision-making by guiding selection of materials and procedures based on their performance and complexity.

02

Conditions studied

  • Healthy Adult Participants
  • Tooth Fracture

Browse trials for

Keywords

  • crown
  • zirconia
  • dental cement
  • clinical trial
03

In context

Tooth Fractures

37 studies on the registry are indexed under Tooth Fractures; 9 are open to participants now.

This study's planned enrollment of 110 is above the median of 40 across 33 interventional studies indexed under Tooth Fractures.

Browse Tooth Fractures studies →

Lead sponsor

Malmö University is the lead sponsor of 44 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Need of one single crown on vital posterior tooth
  • Speak and understand Swedish language
  • Free from dental/oral disease; caries, periodontal disease

Exclusion criteria

Exclusion Criteria:

  • Only individuals who do not meet the inclusion criteria will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
110 participants (estimated)

Study arms

  • Active comparator
    Resin cement

    Tooth-supported zirconia crowns cemented with a resin-based cement

    Other: Resin cement

  • Active comparator
    Glass-ionomer cement

    Tooth-supported zirconia crowns cemented with a glass-ionomer cement

    Other: Glass-ionomer cement

Interventions

  • OtherResin cement

    Zirconia crowns cemented with resin cement

  • OtherGlass-ionomer cement

    Zirconia crowns cemented with glass-ionomer cement

06

What researchers measure

Primary outcomes

  1. Clinical outcome of tooth-supported zirconia crowns from baseline to 1-year follow up

    Clinical performance of tooth supported zirconia crowns assessed using modified CDA criteria, including survival, success, biological complications, technical complications, marginal integrity, discoloration, and surface morphology.

    Time frame: Baseline and 1 year.

  2. Clinical outcome of tooth-supported zirconia crowns from baseline to 3-year follow up

    Clinical performance of tooth supported zirconia crowns assessed using modified CDA criteria, including survival, success, biological complications, technical complications, marginal integrity, discoloration, and surface morphology.

    Time frame: Baseline and 3 years.

  3. Clinical outcome of tooth-supported zirconia crowns from baseline to 5-year follow up

    Clinical performance of tooth supported zirconia crowns assessed using modified CDA criteria, including survival, success, biological complications, technical complications, marginal integrity, discoloration, and surface morphology.

    Time frame: Baseline and 5 years.

  4. Clinical outcome of tooth-supported zirconia crowns from baseline to 10-year follow up

    Clinical performance of tooth supported zirconia crowns assessed using modified CDA criteria, including survival, success, biological complications, technical complications, marginal integrity, discoloration, and surface morphology.

    Time frame: Baseline and 10 years.

Secondary outcomes

  1. Change from Baseline in "Patient-reported Outcome Measurement" at 1 year

    Patient reported and operator reported outcomes will be assessed using structured questionnaires evaluating treatment comfort, clinical handling, and overall satisfaction. Questionnaire scores range from 1 to 5, where higher scores indicate greater satisfaction and improved treatment experience.

    Time frame: Baseline and 1 year.

  2. Change from Baseline in "Patient-reported Outcome Measurement" at 3 year

    Patient reported and operator reported outcomes will be assessed using structured questionnaires evaluating treatment comfort, clinical handling, and overall satisfaction. Questionnaire scores range from 1 to 5, where higher scores indicate greater satisfaction and improved treatment experience.

    Time frame: Baseline and 3 year.

07

Study locations

2 sites
  • Sandin Dentalklinik
    Hörby, Skåne County, Sweden
  • Tandläkare Le
    Malmö, Skåne County 21118, Sweden
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Jul 2028, 25 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2026
First posted
Jun 12, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Jul 2028
CompletionEst.
Jun 2036
Last update
Jun 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07644676
Lead sponsor
Malmö University
Responsible party
Sponsor
First posted
Jun 12, 2026
Start date
Jun 1, 2026
Primary completion
Jul 2028 (estimated)
Completion
Jun 2036 (estimated)
Last update
Jun 12, 2026

Study contacts

Christel Larsson, Ph.D.
principal investigator · Malmö University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion